Yüklüyor......
PCSK9 inhibitors in the prevention of cardiovascular disease
Reducing plasma levels of low-density lipoprotein cholesterol (LDL-C) remains the cornerstone in the primary and secondary prevention of cardiovascular disease. However, lack of efficacy and adverse effects mean that a substantial proportion of patients fail to achieve acceptable LDL-C levels with c...
Kaydedildi:
| Yayımlandı: | J Thromb Thrombolysis |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010583/ https://ncbi.nlm.nih.gov/pubmed/27095708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-016-1364-1 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|